ArticleJournal for immunotherapy of cancer2021
Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.